Welcome to our dedicated page for Dogecoin Cash news (Ticker: CBDS), a resource for investors and traders seeking the latest updates and insights on Dogecoin Cash stock.
Dogecoin Cash, Inc. reports developments around its PrestoDoctor telehealth business and blockchain-referenced financial technology strategy. PrestoDoctor connects patients with licensed healthcare providers for remote consultations and medical cannabis certifications in jurisdictions where permitted by law, and company updates have covered state-market expansion, compliant patient workflows, and cryptocurrency payment acceptance.
Recurring company news also includes blockchain-linked security and unit distributions, transfer-agent and DTC processing updates, and development work tied to digital-asset frameworks. These releases frame the company’s activity across regulated cannabis telehealth, digital payments, and securities-market structures that reference blockchain-based models.
Cannabis Sativa Inc. (CBDS) announced a Letter of Intent to merge with MJ Harvest, Inc. (MJHI). This merger will transition CBDS's operations from telehealth to a vertically integrated cannabis business, consolidating operations in seven states. MJHI, which operates extraction and manufacturing facilities, holds significant cannabis licenses and brand partnerships. The merger terms include MJHI shareholders receiving 2.7 shares of CBDS for each MJHI share. Following the merger, MJHI will cease to exist, with CBDS becoming the surviving entity.
Cannabis Sativa, Inc. (CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the 8th Annual Pennsylvania Cannabis Festival on April 23-24, 2022. This event will take place at Renninger's Farmers Market in Kutztown, PA, featuring over 250 vendors. COO Rob Tankson emphasized the ease of obtaining medical cannabis recommendations during the festival, leveraging proprietary technology to streamline the process. PrestoDoctor has conducted over 100 similar events, maintaining high customer satisfaction ratings. CBDS focuses on telehealth, cannabis-related IP, and ancillary services.
Cannabis Sativa (OTCQB:CBDS) announced that CBGA, a compound in its patented Equadorian Sativa strain, effectively blocks the entry of COVID-19 into human cells, as reported in the Journal of Natural Products. The study indicates that CBGA must be taken orally for potential prevention and treatment of SARS-CoV-2. CEO David Tobias emphasized the importance of this finding and the ongoing research for effective product delivery protocols.
Cannabis Sativa (OTCQB:CBDS) announced that its Brand Ambassador, Randy Lanier, is featured in Netflix's "Need for Weed", part of the "Bad Sport" docuseries. The episode highlights Lanier's dual career as a race car driver and cannabis importer, detailing his achievements, including the 1984 IMSA Championship and Rookie of the Year at the 1986 Indianapolis 500. Lanier now supports cannabis prisoners via Freedom Grow. CEO David Tobias emphasizes the public’s growing acceptance of cannabis legalization, stating that the docuseries tells a critical story in cannabis history.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will be a Diamond Sponsor at the Pennsylvania Cannabis Fall Marketplace on October 2 & 3. The event will be held at Renninger's Farmers Market in Kutztown, featuring free admission and over 50 vendors. PrestoDoctor will provide on-site medical evaluations, utilizing their proprietary technology for efficient sign-ups. As a top-rated online cannabis recommendation service, PrestoDoctor has earned over 17,000 five-star reviews and has helped thousands of patients obtain medical cannabis cards across several states.
Cannabis Sativa (OTCQB:CBDS) has launched Cannabis Sativa Magazine, a new digital news platform focusing on cannabis and hemp industry insights. The magazine aims to cover a variety of topics including investor news, politics, lifestyle, and health. CEO David Tobias emphasized that this new domain enhances their intellectual property portfolio. The company continues to explore direct cannabis involvement through innovations in a patented cannabis strain and aims for vertical integration in the industry to improve control over supply chains and product quality.
Cannabis Sativa, Inc. (OTCQB:CBDS) has signed a Term Sheet to acquire Stratum Brands, a cannabis product manufacturer based in Los Angeles, with a 2020 revenue of $2.8 million. Stratum offers various product lines, including Cobra Extracts and LA Kingpins vapes, distributed across over 50 California dispensaries. The acquisition will involve issuing stock valued at $1.715 million for 49% ownership, with an option for further investment post-audit. This strategic move aims to enhance Cannabis Sativa's manufacturing and distribution capabilities.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported Q1 2021 revenues of $557,323, with its subsidiary PrestoDoctor contributing $482,350 and achieving a margin of 62%. This represents a 13% growth compared to Q1 2020. Management anticipates further growth driven by PrestoDoctor’s expansion into newly legalized states for medical marijuana and effective advertising campaigns in Oklahoma and Iowa. The company aims to enhance its presence in the cannabis market through vertical integration, including cultivating its unique cannabis strain and acquiring dispensaries.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported a 75% increase in revenue for the fiscal year ending December 31, 2020, reaching $2,035,383, compared to $1,159,737 in 2019. This growth is attributed to its 51% owned subsidiary PrestoCorp, which benefited from the surge in telemedicine demand due to COVID-19. However, its other subsidiary, GK Manufacturing and Packaging, reported lower revenues of $94,552 and a cost of revenues of $152,837. The company has invested $750,000 in GKMP, which is facing delays in operations.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the Pennsylvania Cannabis Festival on April 17-18. This festival, featuring free admission, leads up to the popular cannabis celebration on 4/20. PrestoDoctor, known for its telemedicine services, has completed over 100 in-person events. The service allows attendees to quickly complete their medical evaluations without traditional clinic visits. PrestoDoctor has received over 15,000 five-star reviews, indicating strong customer satisfaction.